Clinical trials recruiting in Tarragona, Spain

Phase breakdown

Conditions recruiting in Tarragona, Spain

Recruiting trials in Tarragona, Spain

• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population
  NCT05708235 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
  NCT07169734 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
  NCT04889924 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
  NCT05363319 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs
  NCT06395246 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female)
• DigiDiab Pilot Spain - Nursing Home and Domiciliary Nursing Care
  NCT06605859 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• DigiDiab Pilot: Impact Study Hospital
  NCT06605872 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile
  NCT06452745 · Phase: Not specified · Ages: 50 Years to 70 Years · Sex: All (male and female)
• Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis
  NCT06955221 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: Female
• Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
  NCT06943469 · Phase: Not applicable (e.g. observational or device study) · Ages: 1 Day to 14 Days · Sex: All (male and female)
• Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.
  NCT07242534 · Phase: Phase 4 · Ages: 18 Years to 38 Years · Sex: Female
• Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
  NCT06382948 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Integrated Approach in Frail Older People with Atrial Fibrillation
  NCT06775028 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female)
• MEN-ENDO: Menstrual Stem Cells in Endometriosis
  NCT07578480 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: Female
• MamaConecta: Digital Tool for Maternal Mental Health
  NCT06442774 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• NOPE37: Angiogenic Factors for Managing Term Preeclampsia
  NCT07193680 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
  NCT07484009 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry
  NCT06620757 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
  NCT05781217 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
  NCT06736574 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female)
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Tarragona, Spain?

22 recruiting trials have at least one study site in Tarragona, Spain.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.